摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(pyridin-2-yl)-1-(quinoxalin-6-yl)ethanone | 1025027-47-7

中文名称
——
中文别名
——
英文名称
2-(pyridin-2-yl)-1-(quinoxalin-6-yl)ethanone
英文别名
2-(pyridin-2-yl)-1-(quinoxalin-6-yl)etanone;2-Pyridin-2-yl-1-quinoxalin-6-ylethanone
2-(pyridin-2-yl)-1-(quinoxalin-6-yl)ethanone化学式
CAS
1025027-47-7
化学式
C15H11N3O
mdl
MFCD21032020
分子量
249.272
InChiKey
AKZMHONFBDHASZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.066
  • 拓扑面积:
    55.7
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-(pyridin-2-yl)-1-(quinoxalin-6-yl)ethanone氢溴酸二甲基亚砜 作用下, 以 为溶剂, 反应 2.0h, 以20%的产率得到1-(pyridin-2-yl)-2-(quinoxalin-6-yl)ethane-1,2-dione
    参考文献:
    名称:
    Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
    摘要:
    A series of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles (15a-1) have been synthesized and evaluated for their ALK5 inhibitory activity in cell-based luciferase reporter assays. Among them, 4-[5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-ylmethyl]benzenesulfonamide (15b) and 4-[5-(6-ethylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-ylmethyl]benzene-sulfonamide (15c) showed more than 90% inhibition at 0.5 mu M in a luciferase reporter assay using HaCaT cells transiently transfected with p3TP-luc reporter construct, but inhibited p38 alpha MAP kinase activity only 11 and 8% at a concentration of 10 mu M, respectively. (C) 2008 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2008.03.024
  • 作为产物:
    描述:
    碳酸甲丙酯6-喹喔啉羰酰氯正丁基锂氯化二乙基铝 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 0.83h, 以66%的产率得到2-(pyridin-2-yl)-1-(quinoxalin-6-yl)ethanone
    参考文献:
    名称:
    5-(吡啶-2-基)噻唑类化合物的合成和生物学评估,作为转化生长因子-β1型受体激酶抑制剂。
    摘要:
    已经合成了一系列5-(吡啶-2-基)噻唑(14a-1和15a-1),并在基于细胞的荧光素酶报告基因分析中评估了其对ALK5的抑制活性。其中,3-[[5-(6-甲基吡啶-2-基)-4-(喹喔啉-6-基)噻唑-2-基氨基]甲基]苯甲酰胺e(15i)和3-[[5-(6使用瞬时转染p3TP- luc报告基因构建体和ARE荧光素酶报告基因构建体。
    DOI:
    10.1016/j.bmcl.2008.01.084
点击查看最新优质反应信息

文献信息

  • Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-β type1 receptor kinase inhibitors
    作者:Dae-Kee Kim、Joon Hun Choi、Young Jae An、Ho Soon Lee
    DOI:10.1016/j.bmcl.2008.01.084
    日期:2008.3
    A series of 5-(pyridin-2-yl)thiazoles (14a-l and 15a-l) has been synthesized and evaluated for their ALK5 inhibitory activity in cell-based luciferase reporter assays. Among them, 3-[[5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)thiazol-2-ylamino]methyl]benzamid e (15i) and 3-[[5-(6-ethylpyridin-2-yl)-4-(quinoxalin-6-yl)thiazol-2-ylamino]methyl]benzamide (15k) showed more than 95% inhibition at 0.1
    已经合成了一系列5-(吡啶-2-基)噻唑(14a-1和15a-1),并在基于细胞的荧光素酶报告基因分析中评估了其对ALK5的抑制活性。其中,3-[[5-(6-甲基吡啶-2-基)-4-(喹喔啉-6-基)噻唑-2-基氨基]甲基]苯甲酰胺e(15i)和3-[[5-(6使用瞬时转染p3TP- luc报告基因构建体和ARE荧光素酶报告基因构建体。
  • Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors
    作者:Dae-Kee Kim、Sun Hee Jung、Ho Soon Lee、Purushottam M. Dewang
    DOI:10.1016/j.ejmech.2008.03.024
    日期:2009.2
    A series of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles (15a-1) have been synthesized and evaluated for their ALK5 inhibitory activity in cell-based luciferase reporter assays. Among them, 4-[5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-ylmethyl]benzenesulfonamide (15b) and 4-[5-(6-ethylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-ylmethyl]benzene-sulfonamide (15c) showed more than 90% inhibition at 0.5 mu M in a luciferase reporter assay using HaCaT cells transiently transfected with p3TP-luc reporter construct, but inhibited p38 alpha MAP kinase activity only 11 and 8% at a concentration of 10 mu M, respectively. (C) 2008 Elsevier Masson SAS. All rights reserved.
查看更多